Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Avadel Pharmaceuticals ( NASDAQ:AVDL ) , Cidara Therapeutics ( NASDAQ:CDTX )
As of Nov. 17, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices ...
Avadel Board of Directors Declares Lundbeck Proposal a "Company Superior Proposal"
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION ( EU ...
Avadel Board of Directors Declares Lundbeck Proposal a "Company Superior Proposal" - Avadel Pharmaceuticals ( NASDAQ:AVDL ) , Alkermes ( NASDAQ:ALKS )
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal - Avadel Pharmaceuticals ( NASDAQ:AVDL ) , Alkermes ( NASDAQ:ALKS )
Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) on Friday received an unsolicited proposal from H. Lundbeck A/S for up to $23.00 per ordinary share. The deal consideration includes $21 per share in cash and a non-transferable contingent value right ( CVR ) of potential additional cash payments of ...
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Beyond Meat ( NASDAQ:BYND ) , Avadel Pharmaceuticals ( NASDAQ:AVDL )
U.S. stocks were lower, with the Dow Jones index falling more than 500 points on Friday. Shares of Legence Corp ( NASDAQ:LGN ) rose sharply during Friday's session after delivering mixed third-quarter results in its first earnings report since going public.
Halper Sadeh LLC Encourages TRUE, AVDL, GES Shareholders to Contact the Firm to Discuss Their Rights - Avadel Pharmaceuticals ( NASDAQ:AVDL ) , Guess ( NYSE:GES )
NEW YORK, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Avadel Receives Unsolicited Proposal from Lundbeck
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION ( EU ...
Avadel Receives Unsolicited Proposal from Lundbeck - Avadel Pharmaceuticals ( NASDAQ:AVDL ) , Alkermes ( NASDAQ:ALKS )
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
New Strong Sell Stocks for Nov. 5
AVDL, EPM and FMC have been added to the Zacks Rank #5 (Strong Sell) List on ...
Alkermes Q3 Earnings and Revenues Beat Estimates, 2025 View Raised
ALKS tops Q3 earnings and revenue estimates as Vivitrol, Aristada and Lybalvi fuel growth. 2025 guidance raised after strong demand.
Deal Dispatch: Four Roses, Quantum Computing, Travis Kelce - Air France ( OTC:AFLYY ) , Alkermes ( NASDAQ:ALKS )
Japan's Kirin Holdings is looking to cut a deal on Kentucky bourbon brand Four Roses at around $1 billion. The problem? Young people aren't drinking as much these days. Trade tensions with Canada, a key bourbon buyer, haven't helped either.
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals ...
ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition
Alkermes inks $2.1B deal to acquire Avadel, adding the latter's Lumryz and new growth potential to its portfolio.
Tesla To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Thursday - Canaan ( NASDAQ:CAN ) , Avadel Pharmaceuticals ( NASDAQ:AVDL )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays raised Coca-Cola Co ( NYSE:KO ) price target from $71 to $77.
This Winnebago Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Hologic ( NASDAQ:HOLX ) , Avadel Pharmaceuticals ( NASDAQ:AVDL )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Noah Zatzkin downgraded the rating for Winnebago Industries Inc ( NYSE:WGO ) ...
Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz - Avadel Pharmaceuticals ( NASDAQ:AVDL ) , Jazz Pharmaceuticals ( NASDAQ:JAZZ ) , Alkermes ( NASDAQ:ALKS )
On Wednesday, Alkermes plc ( NASDAQ:ALKS ) agreed to acquire Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) for up to $20 per share in cash, which values Avadel at approximately $2.1 billion.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc ( Nasdaq - AVDL ) , Middlefield Banc Corp. ( Nasdaq - MBCN ) , Heidrick & Struggles International, Inc. ( Nasdaq - HSII ) , Comerica Incorporated ( NYSE - CMA )
BALA CYNWYD, Pa., Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement
DUBLIN, Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all litigation with Jazz Pharmaceuticals Inc. ( "Jazz" ) .
Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement - Avadel Pharmaceuticals ( NASDAQ:AVDL )
DUBLIN, Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) , a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all litigation with Jazz Pharmaceuticals Inc. ( "Jazz" ) .
Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement
DUBLIN, Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all litigation with Jazz Pharmaceuticals Inc. ( "Jazz" ) .
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
DUBLIN, Oct. 13, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to seven ( 7 ) new ...
SKYE Stock Plunges 60% as Obesity Candidate Misses Key Phase II Goal
Skye Bioscience stock nosedives 60% after its investigational obesity candidate, nimacimab, fails to meet the key goal in a mid-stage study.
ESPR Settles Nexletol/Nexlizet Patent Litigation With RDY, Stock Up
Esperion settles Nexletol and Nexlizet patent dispute with Dr. Reddy's, securing U.S. market exclusivity until 2040 and lifting its shares nearly 14%.
Encompass Health Opens First Connecticut Rehab Hospital in Danbury
EHC opens its first Connecticut rehab hospital in Danbury, boosting its nationwide expansion and meeting rising demand for specialized care.
Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding
A Media Snippet accompanying this announcement is available by clicking on this link.
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
DUBLIN, Sept. 10, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to five ( 5 ) new ...
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ ( sodium oxybate ) for Extended-Release Oral Suspension at World Sleep 2025
- 17 abstracts accepted, including one oral presentation ...
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ ( sodium oxybate ) for Extended-Release Oral Suspension at World Sleep 2025 - Avadel Pharmaceuticals ( NASDAQ:AVDL )
- 17 abstracts accepted, including one oral presentation - - Data from the REFRESH real-world study highlight efficacy of once-nightly sodium oxybate when switching from twice-nightly oxybates -
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
- Expands Avadel's pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia ...
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Archrock ( NYSE:AROC ) , Alkermes ( NASDAQ:ALKS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Compass Point analyst Ed Engel initiated coverage on Bullish BLSH with a Neutral rating and ...
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
DUBLIN, Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences: ...
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - Avadel Pharmaceuticals ( NASDAQ:AVDL )
DUBLIN, Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc AVDL, a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences:
HUM Expands Musculoskeletal Care Access With New Value-Based Tie-Ups
Humana teams up with Vori Health, HOPCo and TailorCare to expand value-based musculoskeletal care for Medicare Advantage members.
Acadia & ECU Health Expand Behavioral Care Access in North Carolina
ACHC opens a 144-bed hospital with ECU Health in Greenville, NC, boosting care access and expanding its behavioral health reach.
Corcept Shares Rise 39.6% in YTD: How Should You Play the Stock?
CORT's stock is up 39.6% year to date as relacorilant nears FDA approval for Cushing's syndrome and expands into cancer studies.
Madrigal Gets Conditional Nod for MASH Drug Rezdiffra in EU
MDGL wins EU nod for Rezdiffra as the first and only approved MASH therapy. The drug's launch in Europe is expected in the fourth quarter of 2025.
Are Options Traders Betting on a Big Move in Avadel Pharmaceuticals Stock?
Investors need to pay close attention to Avadel Pharmaceuticals stock based on the movements in the options market lately.
Avadel ( AVDL ) Q2 Revenue Jumps 64%
Avadel Pharmaceuticals Plc ( NASDAQ:AVDL ) , a biopharmaceutical company focused on transforming medicines to improve lives, released its earnings for Q2 2025 on August 7, 2025. The headline news is significant: the company delivered GAAP revenue and earnings that exceeded Wall Street's ...
Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz - Avadel Pharmaceuticals ( NASDAQ:AVDL )
ASL estimates Avadel missed $600 million-$800 million in revenue by delaying Lumryz patient conversion. The company's market cap dropped from $2.5 billion to $900 million as CEO compensation reached $7.4 million. Market-moving news hits Benzinga Pro first-get a 30-minute edge and save 60% this ...
Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation
DUBLIN, June 30, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a biopharmaceutical company focused on transforming medicines to transform lives, announced that, on Friday, June 27, 2025, the U.S. Court of Appeals for the District of Columbia Circuit ( the "Appeals ...
Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation - Avadel Pharmaceuticals ( NASDAQ:AVDL )
DUBLIN, June 30, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc AVDL, a biopharmaceutical company focused on transforming medicines to transform lives, announced that, on Friday, June 27, 2025, the U.S. Court of Appeals for the District of Columbia Circuit ( the "Appeals Court" ) affirmed ...
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
DUBLIN, June 16, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to two new ...
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635 ( c ) ( 4 ) - Avadel Pharmaceuticals ( NASDAQ:AVDL )
DUBLIN, June 16, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc AVDL, a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to two new employees to purchase ...
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ ( sodium oxybate ) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
DUBLIN, June 05, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM has been granted Orphan Drug Designation ( ODD ) from the U.S.
Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - Avadel Pharmaceuticals ( NASDAQ:AVDL )
DUBLIN, Ireland, May 29, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc AVDL, a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on ...
Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer
DUBLIN, May 13, 2025 ( GLOBE NEWSWIRE ) -- DUBLIN, May 13, 2025 - Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a biopharmaceutical company focused on transforming medicines to transform lives, today announced the appointment of Susan Rodriguez as Chief Operating Officer.
Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer - Avadel Pharmaceuticals ( NASDAQ:AVDL )
DUBLIN, May 13, 2025 ( GLOBE NEWSWIRE ) -- DUBLIN, May 13, 2025 - Avadel Pharmaceuticals plc AVDL, a biopharmaceutical company focused on transforming medicines to transform lives, today announced the appointment of Susan Rodriguez as Chief Operating Officer.
Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction
- With this ruling, Avadel can seek and be granted FDA approval for LUMRYZ in Idiopathic Hypersomnia ...
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
DUBLIN, April 10, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to nine ( 9 ) new ...
Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference
DUBLIN, April 08, 2025 ( GLOBE NEWSWIRE ) -- Avadel Pharmaceuticals plc ( Nasdaq: AVDL ) , a biopharmaceutical company focused on transforming medicines to transform lives, today presented at the 24th Annual Needham Virtual Healthcare Conference.
